Impact of PD ‐1 Inhibitor Timing Relative to Locoregional Therapy on Outcomes in uHCC Treated With Lenvatinib‐Based Triple Therapy - Jian He; Jian Chen; Bohua Yu; Fuqun Wei; Weifu Liu; Peishu Huang; Songhui Wu; Xiang You; Zhisheng Chen; Ziqi Lin; Wuhua Guo; Shaowu Zhuang; et al. (Liver International, 2026)